Paper8781663
Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease.
Mena R and 4 others. Acta Neuropathol, 1996. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease. Papers, record 8781663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8781663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Neurofibrillary Tangles | Major topic |
| tau Proteins | Major topic |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Microscopy, Confocal | |
| Middle Aged |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40225859 | Indoxyl sulfate is associated with cognitive impairment in ESRD patients by activating the extrinsic apoptosis in the neuronal cells during differentiating process. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/40225859 | PubMed |
| 40078869 | Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer's disease. | Brain Commun | 2025 | https://conductscience.org/library/papers/40078869 | PubMed |
| 39183704 | dGAE(297-391) Tau Fragment Promotes Formation of Chronic Traumatic Encephalopathy-Like Tau Filaments. | Angew Chem Int Ed Engl | 2024 | https://conductscience.org/library/papers/39183704 | PubMed |
| 38879560 | Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/38879560 | PubMed |
| 37236204 | JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding. | ACS Chem Neurosci | 2023 | https://conductscience.org/library/papers/37236204 | PubMed |
| 37047532 | Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047532 | PubMed |
| 35806324 | Tau as a Biomarker of Neurodegeneration. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806324 | PubMed |
| 35453617 | HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine. | Biomedicines | 2022 | https://conductscience.org/library/papers/35453617 | PubMed |
| 35443732 | Glucose metabolism and AD: evidence for a potential diabetes type 3. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35443732 | PubMed |
| 33915754 | Insoluble Vascular Amyloid Deposits Trigger Disruption of the Neurovascular Unit in Alzheimer's Disease Brains. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33915754 | PubMed |
| 33805376 | Tau Is Truncated in Five Regions of the Normal Adult Human Brain. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33805376 | PubMed |
| 33459640 | Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. | J Alzheimers Dis | 2021 | https://conductscience.org/library/papers/33459640 | PubMed |
| 33329322 | Targeting Tau to Treat Clinical Features of Huntington's Disease. | Front Neurol | 2020 | https://conductscience.org/library/papers/33329322 | PubMed |
| 33218036 | Protein Conformational Dynamics upon Association with the Surfaces of Lipid Membranes and Engineered Nanoparticles: Insights from Electron Paramagnetic Resonance Spectroscopy. | Molecules | 2020 | https://conductscience.org/library/papers/33218036 | PubMed |
| 33132840 | PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease. | Front Cell Neurosci | 2020 | https://conductscience.org/library/papers/33132840 | PubMed |
| 33100967 | Tau Protein and Its Role in Blood-Brain Barrier Dysfunction. | Front Mol Neurosci | 2020 | https://conductscience.org/library/papers/33100967 | PubMed |
| 29895964 | Tau-targeting therapies for Alzheimer disease. | Nat Rev Neurol | 2018 | https://conductscience.org/library/papers/29895964 | PubMed |
| 29700607 | Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia. | J Neural Transm (Vienna) | 2018 | https://conductscience.org/library/papers/29700607 | PubMed |
| 29375308 | A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy. | Front Mol Neurosci | 2017 | https://conductscience.org/library/papers/29375308 | PubMed |
| 28386764 | Roles of tau protein in health and disease. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28386764 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8781663
GET https://conductscience.org/api/papers/v1/8781663/cited_by?page=2